Clinical Trials on Botulinum Toxin, Cosmetic in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
- National University Polyclinics, Singapore
- BioSensics LLC
- MITERA Children's Hospital
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Penza State University
- The University of Texas System Healthcare Safety & Effectiveness Grants Program
- Crovelis
- Midlothian Care Center
- Alfred Benzon Foundation
- Forschungsverbund Rehabilitationswissenschaften Sachsen-Anhalt
- Evolve BioSystems, Inc.
- CirQuest Labs
- No.2 People Hospital of Fuyang City
- Ramboll Group
- Dr Jérôme Rambaud, MD, PhD; Sorbonne University, Paris, France
- University of Houston
- IRCCS-Istituto delle scienze neurologiche di Bologna
- Siddhartha Ganguly
- Universal Biosensors Pty Ltd
- Kolfarma s.r.l. - Italy
- View Full List
Medical Conditions
- Acute Myocardial Infraction or Chest Pain
- Intramural Haematoma of Thoracic Aorta
- Focal Cortical Dysplasia
- Periprosthetic Fracture of the Upper or Lower Limb
- Tumor, Benign
- Attention Deficit Hyperactivity Disorder Symptoms
- Maxillary Deficiency
- Germinal Center B-cell Type (GCB)
- FIGO Stage III Primary Peritoneal Cancer
- Lack of Drug Action
- To Analyze the Frequency of Posttraumatic Stress Disorder in Cases With Awareness and Possible Awareness
- Spondylitis Secondary to Inflammatory Bowel Disease
- Heart Failure With Reduced Ejection Fraction (HFrEF)
- Benign Lymphoproliferative Disorder
- Associated Conditions
- Disorder of Nipple
- Five-year Survival Rate
- Severe Haemophilia A
- Stimulant Use (Diagnosis)
- Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
- View Full List
Drug Interventions
- Etrumadenant
- BAY1902607
- I-131-CLR1404 Injection
- Insulin degludec
- MT-1303-FormB
- NBT-NM108
- Oseltamivir and chinese medicinal herbs
- Cisplatin
- 0.2 mg/kg of oxycodone
- EE 20 microgram with drospirenone 3 mg
- IV methylprednisolone
- Palbociclib
- Ivacaftor
- Total intravenous anesthesia with propofol
- ECx1
- Insulin Glargine
- RVX000222
- OSI-930 and erlotinib
- ZPL-3893787
- Digoxin
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Australia
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Canada
- Contract Research Organizations in Iran
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Suriname
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in Uruguay
- CRO list by country